Myles I. Rosenthal [unable to retrieve full-text content] ROSENTHAL – Myles I., MD passed away on November 13th 2020 at the age of 73 after a long battle with Multiple Myeloma cancer. He was a …Published at Sun, 27 Dec 2020 05:15:00 +0000

What To Expect In 2021 from Ibrutinib Market, Know Why Competition is Rising AMA Latest publication of the Ibrutinib examines the market for Ibrutinib and the various changing dynamics and growth trends. The 100+ page report reviews the growing market for Ibrutinib, market size and estimation till 2026 by key business segments and applications, plus […]

COVID-19 and Multiple Myeloma: What You Need to Know Presented by internationally renowned Dr Brian G.M. Durie from the International Myeloma Foundation, Dr Hira Mian, hematologist from the Juravinski Cancer Centre in Hamilton, Ontario, and patient advocate, David McMullen .

Tributes paid to former Newport County AFC player Alex Beattie Tributes have been paid former Newport County AFC player Alex Beattie, who has died from cancer in the USA aged 67. Mr Beattie, who’s father and brother also played football with the club, was diagnosed with multiple myeloma cancer in July 2019. Mr Beattie, who […]

10 FDA actions that may impact your practice December 23, 2020 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your […]

Google Alert – multiple myeloma Google Alert – multiple myeloma https://www.google.co.in/alerts/feeds/13483114865705844066/2657610053995084043 Lenalidomide Drug Market Investment Analysis | Celgene, Exova https://www.google.com/url?rct=j&sa=t&url=https://lionlowdown.com/news/319089/lenalidomide-drug-market-investment-analysis-celgene-exova/&ct=ga&cd=CAIyHDA1ZmI2ZjVhMGU1ZDdmMTk6Y28uaW46ZW46SU4&usg=AFQjCNF646S5icyOk8pqA5yGC5sAfelUjg https://www.google.com/url?rct=j&sa=t&url=https://lionlowdown.com/news/319089/lenalidomide-drug-market-investment-analysis-celgene-exova/&ct=ga&cd=CAIyHDA1ZmI2ZjVhMGU1ZDdmMTk6Y28uaW46ZW46SU4&usg=AFQjCNF646S5icyOk8pqA5yGC5sAfelUjg <p>JCMR recently Announced&nbsp;<a href=”https://jcmarketresearch.com/report-details/1143453/enquiry”>Lenalidomide Drug</a>&nbsp;study with 200+ market data Tables and Figures spread through Pages and easy to understand detailed TOC on “Global Lenalidomide Drug Market.&nbsp;<a href=”https://jcmarketresearch.com/report-details/1143453/sample”>Global Lenalidomide Drug Market</a>&nbsp;allows you to get different […]

Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA Johnson & Johnson’s Janssen unit has filed a rolling submission for its multiple myeloma CAR-T ciltacabtagene autoleucel (cilta-cel) to the FDA, in hot pursuit of Bristol-Myers Squibb’s delayed rival therapy. Cilta-cel – which targets B-cell maturation antigen (BCMA) – has been submitted as a […]

LifeCare Alliance’s Adopt-a-Family helps those with cancer have a merry Christmas Megan Henry   | The Columbus Dispatch Gracie Davis starts crying every time she sees her Christmas presents sitting by the fireplace. The 69-year-old Far East Side resident received the gifts through the Adopt-a-Family program by LifeCare Alliance and the Columbus Cancer Clinic.  “There’s people out […]

Antengene Announces its US Partner, Karyopharm Therapeutics Inc., has received FDA Approval … –Oral XPOVIO® Approval as Combination Therapy in Patients with Multiple Myeloma After At Least One Prior Therapy Significantly Expands the XPOVIO® Addressable Patient Population – — Oral XPOVIO® is Now the Only Approved Multiple Myeloma Drug Indicated as Part of a Once-Weekly […]

Living With A Chronic Blood Cancer In this webcast, nurse and psychotherapist Bonney Elliott addresses the psychosocial impacts of living with a chronic blood cancer on quality of life, stress, and social and family relationships.